| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/12/2003 | WO2003074064A1 Solid composition containing isoflavonoids for oral administration and method of obtaining same |
| 09/12/2003 | WO2003074058A1 Aerosol formulations containing esters of 3,17-dihydroxy oestratriene derivatives for pulmonary delivery |
| 09/12/2003 | WO2003074055A1 Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist |
| 09/12/2003 | WO2003074041A1 Pharmaceutical compositions |
| 09/12/2003 | WO2003074038A1 Methods for treating diseases related to intraocular pressure |
| 09/12/2003 | WO2003074037A1 Treatment of female sexual dysfunction |
| 09/12/2003 | WO2003074036A1 Novel formulation |
| 09/12/2003 | WO2003074035A1 Transdermal system comprising fentanyl |
| 09/12/2003 | WO2003074034A1 Medicaments containing active ingredients which lower the level of cholesterol with time-delayed active ingredient release |
| 09/12/2003 | WO2003074033A1 Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping |
| 09/12/2003 | WO2003074032A1 Oral administration form for difficulty soluble basic active ingredients which are applied orally |
| 09/12/2003 | WO2003074031A1 Immediate release pharmaceutical granule compositions and a continuous process for making them |
| 09/12/2003 | WO2003074030A1 Modified release oral pharmaceutical composition |
| 09/12/2003 | WO2003074029A1 Fast melt multiparticulate formulations for oral delivery |
| 09/12/2003 | WO2003074028A1 Process for loading and thermodynamically activating drugs on polymers by means of supercritical fluids |
| 09/12/2003 | WO2003074027A2 Self emulsifying drug delivery systems for poorly soluble drugs |
| 09/12/2003 | WO2003074026A1 Drug carriers comprising amphiphilic block copolymers |
| 09/12/2003 | WO2003074025A2 Pressurised metered dose inhalers containing solutions of beta-2 agonists |
| 09/12/2003 | WO2003074023A1 Aerosol formulations for pulmonary administration of medicaments to produce a systemic effect |
| 09/12/2003 | WO2003074022A2 Emulsion containing hydrophobic nanodrops with bound hemoglobin molecules in a hydrophilic phase as a blood substitute |
| 09/12/2003 | WO2003051333B1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents |
| 09/12/2003 | WO2003047630A3 Method for oxygen treatment of unsaturated carbon compounds, novel epoxy-structured material obtained by the method, apparatus for carrying out the method and a therapeutic composition using the material |
| 09/12/2003 | WO2003041757A3 Catheter injectable depot compositions and uses thereof |
| 09/12/2003 | WO2003041684A3 Injectable depot compositions and uses thereof |
| 09/12/2003 | WO2003039596B1 Photodynamic therapy for the treatment of hair loss |
| 09/12/2003 | WO2003033014A3 Novel use of pulmonary surfactant |
| 09/12/2003 | WO2003017932B1 Compositions and methods for targeting cerebral circulation and treatment of headache |
| 09/12/2003 | WO2002098874A3 Inhalation capsules |
| 09/12/2003 | WO2002085415B1 Non-digestible sugar-coated products and process |
| 09/12/2003 | WO2002043686A3 Acid cosmetic, dermatological and pharmaceutical agents |
| 09/12/2003 | WO2002040504A8 Sol-fusin: use of gp64-6his to catalyze membrane fusion |
| 09/12/2003 | WO2002028424A9 Kyberdrug as autovaccines with immune-regulating effects |
| 09/12/2003 | WO2002028362A3 Vaccine composition and stabilisation method |
| 09/12/2003 | WO2002024175A3 Pharmaceutical formulation for pulmonary or nasal administration |
| 09/12/2003 | WO2002005853A3 Compositions containing alpha-2-adrenergic agonist components |
| 09/12/2003 | CA2478612A1 Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist |
| 09/12/2003 | CA2478491A1 Dna nanocage by self-organization of dna and process for producing the same, and dna nanotube and molecule carrier using the same |
| 09/12/2003 | CA2478425A1 Medicaments containing active ingredients which lower the level of cholesterol with time-delayed active ingredient release |
| 09/12/2003 | CA2478424A1 Self emulsifying drug delivery systems for poorly soluble drugs |
| 09/12/2003 | CA2478101A1 Intraorally rapidly disintegrable tablets |
| 09/12/2003 | CA2477964A1 Liquid matrix transforming its phase in living body and oral liquid preparation |
| 09/12/2003 | CA2477926A1 Crystalline polymorphic form of irinotecan hydrochloride |
| 09/12/2003 | CA2477923A1 Multiple-component solid phases containing at least one active pharmaceutical ingredient |
| 09/12/2003 | CA2477392A1 Methods for treating diseases related to intraocular pressure |
| 09/12/2003 | CA2477387A1 Treatment of female sexual dysfunction |
| 09/12/2003 | CA2477075A1 Pharmaceutical and cosmetic compositions comprising plgf-1 |
| 09/12/2003 | CA2476744A1 Solid pharmaceutical compositions comprising lumiracoxib |
| 09/12/2003 | CA2476050A1 Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping |
| 09/12/2003 | CA2475679A1 Flow condition sensor for infusion device |
| 09/11/2003 | WO2003074075A1 Pharmaceutical and cosmetic compositions comprising plgf-1 |
| 09/11/2003 | WO2003074056A1 Form of presentation for 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino] propionic acid ethyl ester to be administered orally |
| 09/11/2003 | WO2003074054A1 Ophthalmic composition comprising ascomycin |
| 09/11/2003 | WO2003074024A1 Formoterol superfine formulation |
| 09/11/2003 | US20030172389 Surfactant protein D for the prevention and diagnosis of pulmonary emphysema |
| 09/11/2003 | US20030171738 Convection-enhanced drug delivery device and method of use |
| 09/11/2003 | US20030171710 Remote controlled transdermal medication delivery device |
| 09/11/2003 | US20030171573 Multivalently interactive molecular assembly, capturing agent, drug carrier, calcium chelating agent, and drug enhancer |
| 09/11/2003 | US20030171496 Drug delivery compositions and medical devices containing block copolymer |
| 09/11/2003 | US20030171439 Methods and compositions for nasal administration of Modafinil |
| 09/11/2003 | US20030171438 Method for treatment of external secretion disorders |
| 09/11/2003 | US20030171437 Pharmaceutical composition |
| 09/11/2003 | US20030171436 Levothyroxine compositions having unique triiodothyronine Tmax properties |
| 09/11/2003 | US20030171430 Dissolving in iodinated poppyseed oil fatty ester |
| 09/11/2003 | US20030171429 Anti-inflammatory and psoriasis treatment and protein kinase inhibition by hydroxyltilbenes and novel stilbene derivatives and analogues |
| 09/11/2003 | US20030171422 Aldose reductase inhibitors; antidiabetic agents |
| 09/11/2003 | US20030171419 Pharmaceutical compositions comprising fluvastatin |
| 09/11/2003 | US20030171417 Double salts of fumaric acid with a carnitine and an amino acid and food supplements, dietary supplements and drugs containing same |
| 09/11/2003 | US20030171408 Therapeutic method of delivering a medicament to avoid irritating effects on membranes of user |
| 09/11/2003 | US20030171402 Method of treating neutrophil-related diseases with topical anesthetics |
| 09/11/2003 | US20030171401 Insertion drug delivery device containing fentanyl |
| 09/11/2003 | US20030171391 Headaches; muscular disorders; antiinflammatory agents |
| 09/11/2003 | US20030171388 Vitamins injected into gel spheres of various colors; mixture of orotic acid and carnitine |
| 09/11/2003 | US20030171382 Pharmaceutical composition for regeneration of cirrhotic liver |
| 09/11/2003 | US20030171344 Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester |
| 09/11/2003 | US20030171343 Preparation for external use is a patch that a pressure-sensitive adhesive layer containing a steroidal antiphlogistic is provided on a support, and the pressure-sensitive adhesive layer further contains a |
| 09/11/2003 | US20030171333 Pharmaceutical composition containing at least a polymer combined with or conjugated to at least a phenylalkylcarboxylic acid salt, conjugate polymers and uses thereof |
| 09/11/2003 | US20030171329 Stable compositions comprising tezacitabine |
| 09/11/2003 | US20030171322 Counterions of polycations used to compact nucleic acids profoundly affect shape and stability of particles formed. Shape is associated with differential serum nuclease resistance and colloidal stability. A surrogate for |
| 09/11/2003 | US20030171307 Equilibrium mixture of azalide isomers, water, and one or more acids, and methods for preparing such compositions, are disclosed. The antibiotic compositions can be advantageously stabilized by adding one or more water-miscible co-solvents |
| 09/11/2003 | US20030171299 Stable, biologically compatible pharmaceutical compositions in the form of water-in-oil microemulsions (w/o), for the sustained release by parenteral administration of active ingredients which are hydrophilic or are made hydrophilic by |
| 09/11/2003 | US20030171296 Pharmaceutical formulations for sustained drug delivery |
| 09/11/2003 | US20030171282 Systemic delivery of parathyroid hormone to a mammalian host is accomplished by inhalation through the mouth of a dispersion of an N-terminal fragment of PTH. It has been found that such respiratory delivery of the PTH fragment |
| 09/11/2003 | US20030171264 Microemulsion preconcentrate; reduced toxicity but high bioavailability; contain cyclosporin A analog ISATx247 (Voclosporin), tocopheryl polyethylene glycol 1000 succinate (Vitamin E TPGS), medium chain triglyceride (MCT) oil, a Tween" emulsifier, and ethanol |
| 09/11/2003 | US20030171259 Method for administering insulin to the buccal region |
| 09/11/2003 | US20030171258 Microparticles comprising (i) a biologically active compound capable of generating an immune response in an animal to which it is administered which is protective against a pathogen; (ii) a polymeric material capable of forming microspheres; |
| 09/11/2003 | US20030171257 Method and related composition employing nanostructures |
| 09/11/2003 | US20030170893 Nanocapsule encapsulation system and method |
| 09/11/2003 | US20030170430 Portable bio-wave device including a bio-wave card and a sticky piece that can enhance immunity of the human body when attached to an ache part of the user |
| 09/11/2003 | US20030170334 Use of Emu Oil and its various fractions as a carrier for antifungal, antibacterial, and antiviral medications & preparations |
| 09/11/2003 | US20030170324 Microencapsulated oil |
| 09/11/2003 | US20030170322 Throat care agents |
| 09/11/2003 | US20030170315 Bioactivation of iron salt, especially an ferric ferrous salt, by adding a magnesium salt (MgCl2); useful as a medicine to treat diseases such as diabetes, freshness preservative agent, and animal and plant growth promoter |
| 09/11/2003 | US20030170314 Carrier; and an atomically disordered, nanocrystalline metal-containing (especially silver) compound; may be antimicrobial, antinflammatory, anticancer, proapoptosis and/or an MMP modulating |
| 09/11/2003 | US20030170313 Polyanionic polymers and polycations in a complex useful for drug delivery; adjuvant to potentiate an immunogenic effect |
| 09/11/2003 | US20030170312 Method for coating solid particles with a thermofusible agent, and resulting coated solid particles |
| 09/11/2003 | US20030170311 Forming, via a microfluidization process, a stable nanosuspension comprising nanodroplets of at least one biologically active agent; and administering, wherein the active agent is absorbed into the bloodstream |
| 09/11/2003 | US20030170310 Fexofenadine complexed with a carbomer; treating seasonal allergic rhinitis or chronic idiopathic urticaria |
| 09/11/2003 | US20030170309 Pharmaceutical compositions containing polymer and drug assemblies |
| 09/11/2003 | US20030170308 Hydrogel compositions |
| 09/11/2003 | US20030170307 Inorganic-polymer complexes for the controlled release of compounds including medicinals |